Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Maciejewski JP, Mufti GJ . Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood 2008; 112: 965–974.

    Article  CAS  Google Scholar 

  2. Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C et al. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood 2009; 113: 6182–6192.

    Article  CAS  Google Scholar 

  3. Makishima H, Cazzolli H, Szpurka H, Dunbar A, Tiu R, Huh J et al. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. J Clin Oncol 2009; 27: 6109–6116.

    Article  CAS  Google Scholar 

  4. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A et al. Mutation in TET2 in myeloid cancers. N Engl J Med 2009; 360: 2289–2301.

    Article  Google Scholar 

  5. Szpurka H, Gondek LP, Mohan SR, Hsi ED, Theil KS, Maciejewski JP . UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation. Leukemia 2009; 23: 610–614.

    Article  CAS  Google Scholar 

  6. Jasek M, Gondek LP, Bejanyan N, Tiu R, Huh J, Theil KS et al. TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. Leukemia 2010; 24: 216–219.

    Article  CAS  Google Scholar 

  7. O'Keefe C, McDevitt MA, Maciejewski JP . Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 2010; 115: 2731–2739.

    Article  CAS  Google Scholar 

  8. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010; 42: 181–185.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by RO1HL-082983, K24 HL-077522, and by a grant from the AA&MDS International Foundation and Robert Duggan Charitable Fund (JPM).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J P Maciejewski.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Makishima, H., Jankowska, A., Tiu, R. et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 24, 1799–1804 (2010). https://doi.org/10.1038/leu.2010.167

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.167

This article is cited by

Search

Quick links